Cormorant Global Healthcare Master Fund, LP is 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT). They have made 13 open-market trades across 12 companies since 2017, most recently 2025-09-30.
CIK 0001618442
10 open-market purchases totalling $178.9M since 2017, against 3 sales. Across 10 scored buys the stock is up 2.5% at ninety days, and 3.2 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 50% | 60% |
| Avg Move | +0.2% | +0.3% | +2.5% |
| Alpha | -0.8% | -2.5% | -3.2% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MLTX | SELL | 2025-09-29 | 2025-10-01 | $7.35 | $73.2M | +54.9% | +46.8% | +92.0% |
| OKUR | SELL | 2025-05-12 | 2025-05-14 | $1.99 | $48K | +23.5% | +44.8% | +9.3% |
| DRUG | BUY | 2024-10-15 | 2024-10-17 | $7.65 | $6.4M | +30.1% | +5.3% | +3.8% |
| CRBP | BUY | 2024-09-20 | 2024-09-24 | $20.01 | $14.0M | +0.5% | -13.1% | -31.2% |
| EYPT | BUY | 2024-04-18 | 2024-04-22 | $18.03 | $21.0M | +9.2% | -37.2% | -51.1% |
| IMRX | SELL | 2024-03-14 | 2024-03-18 | $3.28 | $4.6M | +12.9% | -27.3% | -40.0% |
| EYPT | BUY | 2023-12-04 | 2023-12-06 | $21.81 | $83.1M | -6.0% | +1.2% | +26.8% |
| BMEA | BUY | 2023-03-30 | 2023-04-03 | $30.00 | $12.0M | -16.1% | +7.3% | -25.0% |
| AVTE | BUY | 2021-07-02 | 2021-07-07 | $14.00 | $7.0M | -12.2% | -20.7% | +24.7% |
| VERV | BUY | 2021-06-21 | 2021-06-23 | $19.00 | $5.2M | +27.2% | +39.4% | +32.9% |
| RXDX | BUY | 2021-03-16 | 2021-03-18 | $19.00 | $7.1M | -20.7% | +31.4% | +40.2% |
| OLMA | BUY | 2020-11-23 | 2020-11-23 | $19.00 | $8.1M | -8.1% | -6.7% | -3.3% |
| APLS | BUY | 2017-11-13 | 2017-11-14 | $14.00 | $15.0M | -1.9% | -4.0% | +7.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CRBP | 2,349,231 | $10.6M |
| VERV | 709,224 | $7.9M |
| ICVX | 426,393 | $6.5M |
| VIGL | 616,786 | $5.0M |
| AVTE | 1,530,691 | $4.1M |
| OKUR | 1,813,439 | $3.8M |
| BMEA | 3,570,872 | $3.1M |
| Total | $653.7M |
Shares reported on the most recent Form 4, priced at the 2025-10-01 close.